Kings Point Capital Management’s Eli Lilly LLY Stock Holding History

Kings Point Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$655K	Sell	2,288 -154	-6%	-$39.6K	0.06%	120
2021 Q4	$675K	Buy	2,442 +109	+5%	+$27.6K	0.06%	130
2021 Q3	$539K	Buy	2,333 +304	+15%	+$75K	0.05%	140
2021 Q2	$466K	Buy	2,029 +100	+5%	+$20.1K	0.04%	142
2021 Q1	$360K	Buy	1,929 +33	+2%	+$6.46K	0.04%	151
2020 Q4	$320K	Sell	1,896 -6	-0.3%	-$896	0.03%	144
2020 Q3	$282K	Buy	1,902 +173	+10%	+$26.8K	0.04%	145
2020 Q2	$284K	Hold	1,729	–	–	0.04%	138
2020 Q1	$240K	Hold	1,729	–	–	0.04%	146
2019 Q4	$227K	Hold	1,729	–	–	0.03%	169
2019 Q3	$193K	Buy	1,729 +325	+23%	+$36.2K	0.03%	166
2019 Q2	$156K	Buy	1,404 +850	+153%	+$100K	0.03%	155
2019 Q1	$72K	Hold	554	–	–	0.01%	201
2018 Q4	$64K	Hold	554	–	–	0.01%	197
2018 Q3	$59K	Hold	554	–	–	0.01%	224
2018 Q2	$47K	Hold	554	–	–	0.01%	242
2018 Q1	$43K	Hold	554	–	–	0.01%	250
2017 Q4	$47K	Sell	554 -167	-23%	-$14.2K	0.01%	238
2017 Q3	$62K	Buy	721 +167	+30%	+$13.7K	0.01%	206
2017 Q2	$46K	Hold	554	–	–	0.01%	219
2017 Q1	$47K	Hold	554	–	–	0.01%	226
2016 Q4	$41K	Hold	554	–	–	0.01%	210
2016 Q3	$44K	Hold	554	–	–	0.01%	194
2016 Q2	$44K	Hold	554	–	–	0.01%	195
2016 Q1	$40K	Hold	554	–	–	0.01%	195
2015 Q4	$47K	Hold	554	–	–	0.01%	203
2015 Q3	$46K	Buy	554 +400	+260%	+$33.8K	0.01%	222
2015 Q2	$13K	Hold	154	–	–	﹤0.01%	334
2015 Q1	$11K	Hold	154	–	–	﹤0.01%	348
2014 Q4	$11K	Buy	+154	New	+$10.4K	﹤0.01%	335

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kings Point Capital Management's LLY Position: Q1 2022 in Review

Kings Point Capital Management reduced its Eli Lilly (LLY) stake by 6.3% in Q1 2022, selling an estimated $39.6K and leaving 2,288 shares worth $655K. The position accounts for 0.06% of the portfolio, ranked #120.

Kings Point Capital Management first reported a position in LLY in Q4 2014 and has held it in 30 quarters since. The position peaked at $675K in Q4 2021. 2,345 funds tracked by Wall St. Rank hold LLY as of Q1 2022.

Kings Point Capital Management held 2,288 shares of Eli Lilly worth $655K as of Q1 2022.
Kings Point Capital Management sold 154 Eli Lilly shares in Q1 2022, an estimated $39.6K.
Eli Lilly made up 0.06% of Kings Point Capital Management's portfolio in Q1 2022, its #120 holding.
Kings Point Capital Management first reported a position in Eli Lilly in Q4 2014 and has held it in 30 quarters since.
Kings Point Capital Management's Eli Lilly position peaked at $675K in Q4 2021.
2,345 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.